Seoul National University Hospital: Liver Neoplasms trials

The registry lists 10 Liver Neoplasms studies with Seoul National University Hospital as lead sponsor. 2 are open to participants now and 0 have results posted.

Phase 2 1No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Streamlining Radioembolization for CCC and Metastatic Liver CancerRecruitingNCT07043387
• LT for Unresectable Colorectal Liver MetastasisRecruitingNCT04874259Not applicable
• Enhanced Radiofrequency Ablation for Recurrent HCC Post-TACE Using Twin Internally Cooled-Perfusion ElectrodesCompletedNCT07192172Not applicable
• TACE Using Idarubicin Versus Doxorubicin Chemoemulsion in Patients With Hepatocellular CarcinomaCompletedNCT06114082Phase 2
• Liver CT Dose Reduction With Deep Learning Based ReconstructionCompletedNCT05804799
• No-touch Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma Using Triple Cooled-Wet ElectrodesStatus unknownNCT05449873Not applicable
• Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma With Twin Cooled-wet ElectrodesStatus unknownNCT05449860Not applicable
• Added Value of Contrast-enhanced Ultrasonography for Percutaneous Radiofrequency AblationCompletedNCT05445973Not applicable
• Safety Margin Assessment After RFA Using the Registration of Pre-ablation MRI and Post-ablation CTCompletedNCT02985034
• Pre-procedure Planning for Radiofrequency Ablation Using CT or MR/US FusionCompletedNCT02687113Not applicable